Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Nivolumab × 1 year × Clear all

Sponsor

Conditions

Melanoma 105 Carcinoma, Non-Small-Cell Lung 82 Carcinoma, Renal Cell 60 Neoplasm Metastasis 42 Colorectal Neoplasms 37 Squamous Cell Carcinoma of Head and Neck 36 Neoplasms 31 Lung Neoplasms 28 Carcinoma, Hepatocellular 27 Stomach Neoplasms 26 Urinary Bladder Neoplasms 18 Ovarian Neoplasms 18 Pancreatic Neoplasms 17 Brain Neoplasms 17 Skin Neoplasms 15 Head and Neck Neoplasms 15 Carcinoma, Transitional Cell 15 Prostatic Neoplasms 14 Hodgkin Disease 14 Glioblastoma 14 Colonic Neoplasms 14 Triple Negative Breast Neoplasms 13 Sarcoma 12 Carcinoma, Merkel Cell 12 Uveal Melanoma 11 Recurrence 11 Kidney Neoplasms 11 Breast Neoplasms 11 Small Cell Lung Carcinoma 10 Adenocarcinoma Of Esophagus 10

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡